Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

The lack of a common exchange format for mathematical models in pharmacometrics has been a long‐standing problem. Such a format has the potential to increase productivity and analysis quality, simplify the handling of complex workflows, ensure reproducibility of research, and facilitate the reuse of existing model resources. Pharmacometrics Markup Language (PharmML), currently under development by the Drug Disease Model Resources (DDMoRe) consortium, is intended to become an exchange standard in pharmacometrics by providing means to encode models, trial designs, and modeling steps.

• Publication year

  2015

• Venue

  CPT: Pharmacometrics & Systems Pharmacology

• Publication date

  2015-06-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1002/psp4.57PMID 26225259PMCID 4505825
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Editorial to themed issue: Recent advances in cardiovascular pharmacokinetic–pharmacodynamic modeling and simulation

  2018cited by this paper
• Mixed Effects Models for the Population Approach: Models, Tasks, Methods and Tools

  2015cited by this paper
• Mixed Effects Models for the Population Approach: Models, Tasks, Methods and Tools

  2014cited by this paper
• Drug and Disease Model Resources: A Consortium to Create Standards and Tools to Enhance Model-Based Drug Development

  2013cited by this paper
• Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development

  2012cited by this paper
• BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models

  2010cited by this paper
• Time-dependent structural transformation analysis to high-level Petri net model with active state transition diagram

  2010cited by this paper
• Standards and ontologies in computational systems biology.

  2008cited by this paper
• Pharmacokinetic-Pharmacodynamic Modeling and Simulation.

  2007cited by this paper
• The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models

  2003cited by this paper

• A mathematical framework to study organising principles in graphical representations of biochemical processes

  2024cites this paper
• RESEARCH PAPER Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway

  2023cites this paper
• Computational Models for Clinical Applications in Personalized Medicine—Guidelines and Recommendations for Data Integration and Model Validation

  2022influential citation
• BioSimulators: a central registry of simulation engines and services for recommending specific tools

  2022cites this paper
• Status and Challenges of Reproducibility in Computational Systems and Synthetic Biology

  2021cites this paper
• Physiologically Based Models: Techniques and Applications to Drug Delivery

  2021cites this paper
• Towards reproducible computational drug discovery

  2020cites this paper
• : From the

  2020cites this paper
• Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of In Vivo Clinical Studies: Current Status, Challenges, and Opportunities.

  2020cites this paper
• Overview: Standards for Modeling in Systems Medicine

  2020cites this paper
• Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network

  2019cites this paper
• Reproducible pharmacokinetics

  2019cites this paper
• Scalable and Reproducible Modeling and Simulation for Heterogeneous Populations

  2019cites this paper
• BioModels—15 years of sharing computational models in life science

  2019cites this paper
• SQSTM1/p62: A Potential Target for Neurodegenerative Disease.

  2019cites this paper
• Role of Clinical Pharmacokinetics Studies in Contemporary Oncology Drug Development

  2018cites this paper
• Getting Digital Assets from Public–Private Partnership Research Projects through “The Valley of Death,” and Making Them Sustainable

  2018cites this paper
• Complex Bayesian Modeling Workflows Encoding and Execution Made Easy With a Novel WinBUGS Plugin of the Drug Disease Model Resources Interoperability Framework

  2018cites this paper
• Modeling tumor growth inhibition and toxicity outcome after administration of anticancer agents in xenograft mice: A Dynamic Energy Budget (DEB) approach.

  2018cites this paper
• Reproducible Research Using Biomodels

  2018cites this paper
• The Standard Output: A Tool‐Agnostic Modeling Storage Format

  2018cites this paper
• Toward reproducible disease models using the Systems Biology Markup Language

  2018influential citation
• Open source tools and standardized data in cancer systems biology

  2018cites this paper
• PharmML in Action: an Interoperable Language for Modeling and Simulation

  2017cites this paper
• Computational investigation of biological and technical variability in high throughput phenotyping and cell line identification

  2017cites this paper
• Thoughtflow: Standards and Tools for Provenance Capture and Workflow Definition to Support Model‐Informed Drug Discovery and Development

  2017cites this paper
• Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway

  2017cites this paper
• Quantitative Simulation on Concentration-Time Profiles of Oxycodone Co-administration with Diazepam

  2017cites this paper
• Model Description Language (MDL): A Standard for Modeling and Simulation

  2017cites this paper
• How Modeling Standards, Software, and Initiatives Support Reproducibility in Systems Biology and Systems Medicine

  2016influential citation
• MultiCellDS: a community-developed standard for curating microenvironment-dependent multicellular data

  2016cites this paper
• Modeling and Simulation Tools: From Systems Biology to Systems Medicine.

  2016cites this paper
• Harnessing Big Data for Systems Pharmacology

  2016cites this paper
• ProbOnto: ontology and knowledge base of probability distributions

  2016cites this paper
• A Tutorial on Pharmacodynamic Scripting Facility in Simcyp

  2016cites this paper
• The promises of quantitative systems pharmacology modelling for drug development

  2016cites this paper
• The Human Physiome: how standards, software and innovative service infrastructures are providing the building blocks to make it achievable

  2016cites this paper
• Sharing formats for disease models

  2016cites this paper
• Implementing a Domain-specific Language for Model-based Drug Development

  2015cites this paper
• An algorithm to detect and communicate the differences in computational models describing biological systems

  2015cites this paper
• The European Bioinformatics Institute in 2016: Data growth and integration

  2015cites this paper
• Improving Collaboration by Standardization Efforts in Systems Biology

  2014cites this paper